These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22784101)

  • 1. Effects of atorvastatin on systemic and renal nitric oxide in healthy man.
    Mose FH; Larsen T; Bech JN; Pedersen EB
    Clin Exp Hypertens; 2013; 35(2):148-57. PubMed ID: 22784101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
    Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of atorvastatin on glomerular filtration rate, tubular function, blood pressure, and vasoactive hormones in patients with type 2 diabetes.
    Paulsen L; Matthesen SK; Bech JN; Starklint J; Pedersen EB
    J Clin Pharmacol; 2010 Jul; 50(7):816-22. PubMed ID: 20056802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease.
    Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 2014 Oct; 78(4):789-99. PubMed ID: 24697877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
    Paulsen L; Holst LM; Bech JN; Starklint J; Pedersen EB
    Scand J Clin Lab Invest; 2009; 69(3):323-9. PubMed ID: 19051099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
    Larsen T; Mose FH; Bech JN; Pedersen EB
    Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Pedersen EB
    Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
    Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
    Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
    Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
    Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects.
    Tannous M; Cheung R; Vignini A; Mutus B
    Thromb Haemost; 1999 Nov; 82(5):1390-4. PubMed ID: 10595624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxytocin in normal man during low and high sodium diets.
    Rasmussen MS; Simonsen JA; Sandgaard NC; Høilund-Carlsen PF; Bie P
    Acta Physiol Scand; 2004 Jun; 181(2):247-57. PubMed ID: 15180798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin improves sodium handling and decreases blood pressure in salt-loaded rats with chronic renal insufficiency.
    Juncos LI; Martín FL; Baigorria ST; Pasqualini ME; Fiore MC; Eynard AR; Juncos LA; García NH
    Nutrition; 2012 Sep; 28(9):e23-8. PubMed ID: 22698702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral contraceptives on the nitric oxide system and renal function.
    Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
    Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
    Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.